The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.
Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock
Abstract
Summary: Objective Septic shock is one of various causes of nonthyroidal illness syndrome (NTIS). In humans, the molecular mechanisms involved in NTIS are mostly unknown. The aim of this study was to investigate, in patients with NTIS secondary to septic shock, changes in the expression of genes involved in the actions of thyroid hormones and in the activity of deiodinase enzymes, in two tissues important for protein and energy metabolism, skeletal muscle (SM) and subcutaneous adipose tissue (SAT). Design Hospitalized patients were divided into a control and a septic shock NTIS group. Measurement Serum collection for biochemical measurements, and SM and SAT biopsies for mRNA expression analysis of thyroid hormone receptors (THRB1, THRA1), retinoid X receptors (RXRA, RXRB, RXRG), nuclear receptor corepressor (NCOR1), silencing mediator of retinoid and thyroid hormone receptor (SMRT), steroid receptor coactivator (SRC1), type 1 and 2 deiodinases (D1, D2), monocarboxylate transporter 8 (MCT8), SECIS binding protein 2 (SBP2) and uncoupling protein 3 (UCP3) as well as D1, D2 and D3 enzyme activity measurements. Results The NTIS group had lower serum TSH, and free T3 and higher rT3 than controls. D1 and D3 were detected in SAT, with no differences found between the two groups; SM had very low D2 activity and again no differences were found between groups; D3 activity in SM was higher in NTIS than controls. SM expression of THRB1, RXRG and D2 was lower and RXRA higher in NTIS than controls. SAT from NTIS patients had lower MCT8, THRB1, THRA1, RXRG and SMRT, and higher UCP3 expression than controls. Conclusions In patients with septic shock NTIS tissue responses are orientated to decrease production and increase degradation (muscle) or decrease uptake (adipose tissue) of T3, as well as to decrease thyroid hormone actions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, muscle UCP3 and myogenin mRNA expression, which are both T3 target genes, are unaltered in septic patients compared to controls [29].”
From An update on non-thyroidal illness syndrome (2021) · cites this paper as [29]
In the citing paper
“Muscle DIO2 is differentially affected during illness. Acute inflammation in mice increases muscle Dio2 mRNA expression, while bacterial sepsis decreases Dio2 mRNA expression both in mice [28] and humans [29].”
From An update on non-thyroidal illness syndrome (2021) · cites this paper as [29]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G. W., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Oñate, S. A., Tsai, S. Y., Tsai, M., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,242
Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome
WARTOFSKY, L., & BURMAN, K. D. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-164 · Cited by 916
Deiodinases: implications of the local control of thyroid hormone action
Bianco, A. C., & Kim, B. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29812 · Cited by 845
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725
Self-citationDangerous dogmas in medicine: the nonthyroidal illness syndrome
De Groot, L. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5364 · Cited by 505
Peeters, R. P., Wouters, P. J., Kaptein, E., van Toor, H., Visser, T. J., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022013 · Cited by 452
Self-citationMutations in SECISBP2 result in abnormal thyroid hormone metabolism
Dumitrescu, A. M., Liao, X.-H., Abdullah, M. S. Y., Lado-Abeal, J., Majed, F. A., Moeller, L. C., Boran, G., Schomburg, L., Weiss, R. E., & Refetoff, S. (2005) · Nature Genetics · doi:10.1038/ng1654 · Cited by 412
Self-citationHennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394
Self-citationType 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360
den Berghe, G. V., de Zegher, F., Baxter, R. C., Veldhuis, J. D., Wouters, P. J., Schetz, M., Verwaest, C., der Vorst, E. V., Lauwers, P., Bouillon, R., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4575 · Cited by 234
Fliers, E., Guldenaar, S. E. F., Wiersinga, W. M., & Swaab, D. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4404 · Cited by 206
De Groot, L. J. (2006) · Critical Care Clinics · doi:10.1016/j.ccc.2005.10.001 · Cited by 188
Fekete, C., Gereben, B., Doleschall, M., Harney, J. W., Dora, J. M., Bianco, A. C., Sarkar, S., Liposits, Z., Rand, W., Emerson, C., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1439 · Cited by 179
Plikat, K., Langgartner, J., Buettner, R., Bollheimer, L. C., Woenckhaus, U., Schölmerich, J., & Wrede, C. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.09.020 · Cited by 156
Tissue Thyroid Hormone Levels in Critical Illness
Peeters, R. P., van der Geyten, S., Wouters, P. J., Darras, V. M., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1013 · Cited by 145
Self-citationFeingold, K. R., Kim, M. S., Shigenaga, J. K., Moser, A., & Grünfeld, C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2003 · Cited by 142
Reduced tissue thyroid hormone levels in fatal illness
Arem, R., Wiener, G. J., Kaplan, S. G., Kim, H.-S., Reichlin, S., & Kaplan, M. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90266-q · Cited by 129
Boelen, A., Kwakkel, J., Alkemade, A., Renckens, R., Kaptein, E., Kuiper, G., Wiersinga, W. M., & Visser, T. J. (2005) · Endocrinology · doi:10.1210/en.2005-0608 · Cited by 117
Self-citationLim, C. F., Docter, R., Visser, T. J., Krenning, E. P., Bernard, B. F., van Toor, H., de Jong, M., & HENNEMANN, G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8496307 · Cited by 114
Self-citationA potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
Nagaya, T., Fujieda, M., Otsuka, G., Yang, J.-P., Okamoto, T., & Seo, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7771 · Cited by 107
Role of cytokines in the pathogenesis of the euthyroid sick syndrome
Bartalena, L., Bogazzi, F., Brogioni, S., Grasso, L., & Martino, E. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380603 · Cited by 100
The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice
Boelen, A., Platvoet-ter Schiphorst, M. C., Bakker, O., & Wiersinga, W. M. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1460475 · Cited by 93
The controversy of the treatment of critically ill patients with thyroid hormone
Stathatos, N., Levetan, C. S., Burman, K. D., & Wartofsky, L. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2001.0164 · Cited by 90
Endocrine measurements in survivors and non-survivors from critical illness
Ray, D. C., MacDuff, A., Drummond, G. B., Wilkinson, E., Adams, B., & Beckett, G. J. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1427-y · Cited by 82
Hosoi, Y. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3293 · Cited by 80
Euthyroid Sick Syndrome and the Role of Cytokines
Papanicolaou, D. A. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010060303031 · Cited by 72
Jakobs, T., Mentrup, B., Schmutzler, C., Dreher, I., & Köhrle, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460559 · Cited by 72
Corepressors: Custom Tailoring and Alterations While you Wait
Goodson, M. L., Jonas, B. A., & Privalsky, M. L. (2005) · Nuclear Receptor Signaling · doi:10.1621/nrs.03003 · Cited by 71
THYROID HORMONE RECEPTOR EXPRESSION IN THE "SICK EUTHYROID" SYNDROME
WILLIAMS, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92930-9 · Cited by 71
Isoform-dependent actions of thyroid hormone nuclear receptors: Lessons from knockin mutant mice
Cheng, S. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.003 · Cited by 67
Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00155.2002 · Cited by 64
Kwakkel, J., Wiersinga, W. M., & Boelen, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06354 · Cited by 56
Kaptein, E. M., Kaptein, J. S., CHANG, E. I., EGODAGE, P. M., Nicoloff, J. T., & Massry, S. G. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-4-606 · Cited by 55
Self-citationHaugen, B. R., Jensen, D. R., Sharma, V., Pulawa, L. K., Hays, W. R., Krężel, W., Chambon, P., & Eckel, R. H. (2004) · Endocrinology · doi:10.1210/en.2003-1401 · Cited by 53
The euthyroid sick syndrome: Is there a physiologic rationale for thyroid hormone treatment?
Stathatos, N., & Wartofsky, L. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03349153 · Cited by 52
Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients.
Angstwurm, M., Schopohl, J., & Gaertner, R. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510047 · Cited by 51
Induction of Type 1 Iodothyronine Deiodinase to Prevent the Nonthyroidal Illness Syndrome in Mice
Yu, J., & Koenig, R. J. (2006) · Endocrinology · doi:10.1210/en.2005-1443 · Cited by 46
Thyroid Hormone Receptor Isoform Expression in Livers of Critically Ill Patients
Thijssen‐Timmer, D. C., Peeters, R. P., Wouters, P. J., Weekers, F., Visser, T. J., Fliers, E., Wiersinga, W. M., Bakker, O., & den Berghe, G. V. (2007) · Thyroid · doi:10.1089/thy.2006.0164 · Cited by 39
Self-citation
Research works printed but not linked: 3
- 10.1210/jc.82.12.4032 · DOI · Paper page
- 10.1210/jc.83.2.309 · DOI
- 10.1210/jc.76.5.1165 · DOI
Cited by
Sorted by citations
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Thyroid Hormones, Oxidative Stress, and Inflammation
Mancini, A., Segni, C. D., Raimondo, S., Olivieri, G., Silvestrini, A., Meucci, E., & Currò, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6757154 · Cited by 558
Thyroid function in critically ill patients
Fliers, E., Bianco, A. C., Langouche, L., & Boelen, A. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00225-9 · Cited by 441
Mechanisms behind the non-thyroidal illness syndrome: an update
Warner, M., & Beckett, G. J. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0412 · Cited by 438
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Metadata
- Authors
- Rodriguez‐Perez, A., Palos‐Paz, F., Kaptein, E., Visser, T. J., Dominguez‐Gerpe, L., Alvarez‐Escudero, J., & Lado‐Abeal, J.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Erasmus MC (NL)
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2007-10-08
- Volume
- 68
- Issue
- 5
- Pages
- 821-827
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1988529706
- Cited by
- 110
- References
- 42
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 4 · 2020: 11 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 2 · 2013: 8 · 2012: 3
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- low T3 syndrome, septic shock, thyroid hormone receptor, thyroid hormone deiodinases, skeletal muscle, subcutaneous adipose tissue, retinoid X receptor, thyroid hormone action, reverse T3, UCP3, MCT8, gene expression, energy metabolism
- MeSH terms
- Adipose Tissue, Adult, Aged, Aged, 80 and over, Female, Humans, Iodide Peroxidase, Male, Middle Aged, Shock, Septic, Thyroid Diseases, Gene Expression Regulation, Enzymologic, Case-Control Studies, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review